In mouse models of PDAC, depletion of neutrophils using anti-Ly6G antibodies or inhibition of CXCR2 signaling results in reduced tumor growth, abrogation of metastasis, and improved influx of cytotoxic T cells, which enables an improved checkpoint inhibition therapy response13,59,60. The gene discussed is CXCR2; the disease is neoplasm.